Preparation and in vitro quality evaluation of curcumin supersaturated self-nanoemulsion
【Abstract】In order to improve the supersaturation and maintenance time of drug dispersion in curcumin self-nanoemulsion (CUR-SNEDDS), precipitation inhibitors (PPIs) were introduced to prepare curcumin supersaturated self-emulsion (CUR-SSNEDDS). The composition of CUR-SNEDDS prescriptions was selected through the solubility test, the compatibility of oil phase and surfactant, the investigation of the emulsifying ability of the surfactant and the drawing of the pseudo-ternary phase diagram. Analytic hierarchy process was used in combination with central composite design-response surface method to optimize the prescription. The type and dosage of precipitation inhibitors (PPIs) were selected to maintain the supersaturated concentration and duration of CUR in artificial gastrointestinal fluids. At the same time, polarizing microscope was used to evaluate the crystallization inhibition effect and the quality and in vitro release behavior of CUR-SSNEDDS. The prepared CUR-SSNEDDS prescription was capryol 90-kolliphor RH40-transcutol HP-Soluplus (7.93:66.71:25.36:5), with the drug loading of (65.12 ± 1.25) mg·g−1. CUR-SSNEDDS was transparent yellow, and the nanoemulsion droplets were spherical with uniform distribution. The emulsification time was (21.02 ± 0.13) s, the average particle size was (57.03 ± 0.35) nm, the polydispersity index(PDI) was (0.23 ± 0.01), and the Zeta potential was (−18.10 ± 1.30) mV. CUR-SSNEDDS significantly inhibited the generation and growth of crystals after in vitro dilution. The supersaturation could be maintained above 10 within 2 h, and the dissolution rate and degree of CUR in artificial gastrointestinal fluid were significantly increased. Soluplus could effectively maintain the supersaturated state of CUR and enhance CUR dissolution in vitro.
【Keywords】 curcumin; supersaturated self-nanoemulsion; artificial gastrointestinal fluid; drug loading; supersaturation;
 FEENEY O M, CRUM M F, MCEVOOY C L, et al. 50 years of oral lipid-based formulations: provenance, progressand future perspectives [J]. Adv Drug Deliv Rev, 2016, 101: 167.
 CHENG H, LV H X. Advances in research and application of supersaturating drug delivery system [J]. Progress in Pharmaceutical Sciences, 2019, 43 (3): 181 (in Chinese).
 LIU T T, YANG B X, GUO Y Y, et al. Solubilization and protection of curcumin by mixed surfactants [J]. Acta Pharmaceutica Sinica, 2019, 54 (1): 8 (in Chinese).
 LIANG Q, WANG Y R, DENG Y Y. Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin [J]. China Journal of Chinese Materia Medica, 2019, 44 (15): 3305 (in Chinese).
 ZHANG Y G, WU S Z, LIU Y C, et al. Study of IL-2 and IL-12 Effects of curcumin on S180 tumor-bearing mice [J]. Pharmacy Today, 2011, 21 (12): 736 (in Chinese).
 SONG W, CUI Y, ZHANG J B, et al. Effects of curcumin on proliferation inhibition of human pancreatic cancer cell and the influence on wnt signaling pathway [J]. World Chinese Medicine, 2018, 13 (5): 1226 (in Chinese).
 LIU W H, YUAN J B, ZHANG F, et al. Curcumin inhibits proliferation, migration and invasion of gastric cancer cells via Wnt3a/β-catenin/EMT signaling pathway [J]. China Journal of Chinese Materia Medica, 2019, 44 (14): 3107 (in Chinese).
 YAN L J, WANG S B, WANG X Q, et al. Protective effect and mechanism of curcumin on aorta in rats with metabolic syndrome [J]. China Journal of Chinese Materia Medica, 2019, 44 (21): 4685 (in Chinese).
 TONNESEN H H, MASSON M, LOFTSSON T. Studies of curcumin and curcuminoids. ⅩⅩⅤⅡ. Cyclodextrin complexation: solubility, chemical and photochemical stability [J]. Int J Pharm, 2002, 244: 127.
 IPAR V S, DSOUZA A, DEVARAJAN P V. Enhancing curcumin oral bioavailability through nanoformulations [J]. Eur J Drug Metab Pharmacokinet, 2019, 44 (4): 459.
 PETCHSOMRIT A, SERMKAEW N, WIWATTANAPATAPEE R. Self-microemulsifying, reconstituted granules for oral administration of curcumin: development and in vitro characterization [J]. Lat Am J Pharm, 2018, 37: 740.
 LIU Y, HUANG P W, HOU X F, et al. Hybrid curcumin-phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancer [J]. Int J Nanomedicine, 2019, 14: 3311.
 LI Q P, ZHAI W W, JIANG Q L, et al. Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy [J]. Int J Pharm, 2015, 490: 22.
 LI Q P, DAI J D, ZHAI W W, et al. Optimization and characterization of curcumin-piperine dual drug loaded self-microemulsifying drug delivery system by simplex lattice design [J]. China Journal of Chinese Materia Medica, 2014, 39 (20): 3936 (in Chinese).
 LAI Z T, DING H B, JIANG Q Y, et al. Preparation and in vitro quality evaluation of silybin supersaturated self-microemulsion drug delivery system [J]. Chinese Traditional and Herbal Drugs, 2019, 50 (17): 4091 (in Chinese).
 QIAN J, MENG H J, XIN L, et al. Self-nanoemulsifying drug delivery systems of myricetin: formulation development, characterization, and in vitro and in vivo evaluation [J]. Colloids Surf B Biointerfaces, 2017, 160: 101.
 THOMAS N, MULLERTZ A, GRAF A, et al. Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems [J]. J Pharm Sci, 2012, 101 (5): 1721.
 MA Z B, LI X F, XIE L, et al. Preparation of emodin-cinnamaldehyde self-microemulsions and in vitro evaluation [J]. Chinese Traditional Patent Medicine, 2019, 41 (1): 7 (in Chinese).
 KALLAKUNTA V R, BANDARI S, JUKANTI R, et al. Oral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluation [J]. Powder Technol, 2012, 221: 375.
 RAO Z C, SI L Q, GUAN Y B, et al. Inhibitive effect of cremophor RH40 or tween 80-based self-microemulsiflying drug delivery system on cytochrome P450 3A enzymes in murine hepatocytes [J]. J Huazhong Univ Sci Technol Med Sci, 2011, 30 (5): 562.
 REN F Z, JING Q F, CUI J B, et al. Self-nanoemulsifying drug delivery system (SNEDDS) of anethole trithione by combined use of surfactants [J]. J Disper Sci Technol, 2009, 30 (5): 664.
 YOO J H, SHANMUGAM S, THAPA P, et al. Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein [J]. Arch Pharm Res, 2010, 33: 417.
 KANG J H, OH D H, OH Y K, et al. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS) [J]. Eur J Pharm Biopharm, 2012, 80 (2): 289.
 WANG L, HUANG T, ZENG J. 共聚物Soluplus在药物新剂型与新技术中的应用进展 [J]. China Pharmacy, 2016, 27 (19): 2703 (in Chinese).
 SONG S, YU H Z, ZHU C L, et al. Cyclosporin A osmotic pump tablets which can form supersaturated micelles [J]. Acta Pharmaceutica Sinica, 2019, 54 (1): 22 (in Chinese).